MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The effect of levodopa on the blood activity of calpains in patients with Parkinson’s disease

    Z. Muruzheva, M. Absalyamova, M. Karpenko (Saint-Petersburg, Russian Federation)

    Objective: To evaluate the effect of levodopa on the blood activity of calpains in patients with PD Background: Parkinson's disease (PD) is a chronic progressive…
  • 2023 International Congress

    Chorea improvements over time with once-daily valbenazine treatment in adults with Huntington disease

    E. Furr Stimming, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To describe the effects of valbenazine (VBZ) over time on chorea in adults with Huntington disease (HD). Background: The Ph3 KINECTTM-HD (NCT04102579) trial met…
  • 2023 International Congress

    Dyspnea and quality of life in Parkinson’s: a mixed methods study

    M. Darabseh, A. Aburub (Amman, Jordan)

    Objective: This study aimed to explore dyspnea experiences in people living with Parkinson’s PlwP who are walking independently. Background: Dyspnea is one of the non-motor…
  • 2023 International Congress

    Acute laryngeal stridor in the emergency department: pandemic or additional sign?

    F. Gomes, C. Silva, D. Damas, I. Carvalho, I. Cunha, A. Brás, A. Morgadinho, F. Moreira (Coimbra, Portugal)

    Objective: To highlight the importance of early recognition of the broader spectrum of clinical features of MSA and specially the sleep-related breathing disorders, as stridor.…
  • 2023 International Congress

    Spectrum of hyperkinetic movement disorders in a Tunisian Cohort: an observational study

    S. Laroussi, S. Daoud, N. Bouattour, S. Sakka, K. Moalla, M. Damak, N. Farhat, C. Mhiri (Sfax, Tunisia)

    Objective: Recall clinical situations of hyperkinetic movement disorders (HMD) in a Tunisian cohort. Background: HMD result from a dysfunction of the basal ganglia(BG) and are…
  • 2023 International Congress

    Deep Brain Stimulation Duration and Changes in Basal Ganglia Excitatory/Inhibitory Balance in Children and Young Adults with Dystonia

    T. Larsh, D. Gilbert, S. Vadivelu, S. Wu (Cincinnati, USA)

    Objective: We sought to explore associations between basal ganglia aperiodic signals and time since deep brain stimulation (DBS) implantation in children and young adults with…
  • 2023 International Congress

    Transforming Parkinson’s Care in Africa: community engagement and involvement activities

    N. Fothergill-Misbah, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: To outline the role of community engagement and involvement (CEI) in global health research to support people with Parkinson’s and their caregivers across Africa.…
  • 2023 International Congress

    Reliability of Indonesian Version Wearing Off Questionnaire

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: This study measure the reliability of Indonesia version wearing off (WO) questionnaire for PD patients. Background: The wearing off phenomenon is disabling complication of…
  • 2023 International Congress

    Pediatric Myoclonus-Dystonia misdiagnosed as CASPR2 encephalitis – a diagnostic challenge

    L. Dias, R. Pissarra, J. Fonseca, C. Melo, M. Sampaio, R. Sousa (Porto, Portugal)

    Objective: Describe the clinical/laboratory challenges in diagnosis of myoclonus-dystonia at a young age Background: SGCE Myoclonus-Dystonia (SGCE-M-D) is a genetic movement disorder characterized by multifocal…
  • 2023 International Congress

    Pain reduction in adults with cervical dystonia and moderate or severe baseline pain following repeated injections of incobotulinumtoxinA: an analysis of pooled data from phase 3 and 4 studies

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess pain reduction in incobotulinumtoxinA (incoA)-treated adults with cervical dystonia (CD)-related moderate or severe pain at baseline using pooled data from four phase…
  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley